FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Cisatracurium Besylate Injection
Status: Currently in Shortage
»Date first posted: 04/08/2020
»Therapeutic Categories: Anesthesia

Expand all

Abbvie (Revised 07/30/2020)

Company Contact Information:
800-255-5162

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mg/mL, 5 mL Single-dose vial (NDC 0074-4378-05, 0074-4378-24, 0074-4378-36) Limited availability Please check with your wholesaler for available inventory Demand increase for the drug
2 mg/mL, 10 mL Multiple-dose vial (NDC 0074-4380-10, 0074-4380-79, 0074-4380-81) On backorder. Next replenishment to be confirmed Please check with your wholesaler for available inventory Demand increase for the drug
10 mg/mL, 20 mL Single-dose vial (NDC 0074-4382-20, 0074-4382-91, 0074-4382-93) Limited availability Please check with your wholesaler for available inventory Demand increase for the drug

AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.) (New 07/16/2020)

Company Contact Information:
888-238-7880

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
20 mg / 10 mL Multiple-Dose Vial, Package of 10 vials (ndc 55150-286-10) Limited quantity available Next shipment anticipated Sept. 2020 Demand increase for the drug

Fresenius Kabi USA, LLC (Revised 07/13/2020)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mg (base) per 5 mL (2 mg per mL), Single dose vial, PF, (NDC 63323-416-05) Available Check wholesalers for inventory Demand increase for the drug
20 mg per 10 mL (2 mg per mL), Multiple dose vial, (NDC 63323-417-10) Backordered. Next release not available at this time. Check wholesalers for inventory Demand increase for the drug
200 mg per 20 mL (10 mg per mL), Single dose vial, PF, (NDC 63323-418-20) Backordered. Next release not available at this time. Check wholesalers for inventory Demand increase for the drug

Hospira, Inc. (Revised 07/31/2020)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10mg/5mL (2mg/mL) Single Dose Vial (NDC 00409-1098-02) Next Delivery and Estimated Recovery: October 2020 Demand increase for the drug
200 mg/20 mL (10 mg/mL) Single Dose Vial (NDC 00409-1103-01) Available Other
20mg/10mL (2mg/mL) Multi-Dose Vial (NDC 00409-1208-01) Next Delivery: July 2020; Estimated Recovery: November 2020 Demand increase for the drug

Meitheal Pharmaceuticals, Inc. (Revised 07/22/2020)

Company Contact Information:
844-824-8426

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mg per 5 mL single dose vial (NDC 71288-712-06) Backordered. Next Delivery: July 2020, August 2020 and November 2020. Prioritized manufacturing and increased production due to overall demand. Demand increase for the drug
200 mg per 20 mL single dose vial (NDC 71288-713-21) Backordered. Next Delivery: July 2020, August 2020 and November 2020. Prioritized manufacturing and increased production due to overall demand. Demand increase for the drug
20 mg per 10 mL multi dose vial (NDC 71288-712-11) Backordered. Next Delivery: July 2020, August 2020 and November 2020. Prioritized manufacturing and increased production due to overall demand. Demand increase for the drug

Sandoz (Reverified 07/31/2020)

Company Contact Information:
800-525-8747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2mg/ml; 5mL (NDC 0781-3150-95) Available
2mg/mL; 10mL (NDC 0781-3152-95) Available
1-mg/mL; 20mL (NDC 0781-3153-95_ Available

Somerset Therapeutics, LLC (New 04/08/2020)

Company Contact Information:
732-554-1019

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2mg/mL 10 vials (NDC 70069-141-10) Limited supply available. Please contact wholesaler for availability. Somerset is ramping up production to meet increased demand. Demand increase for the drug
2mg/ml 10 vials (NDC 70069-161-10) Limited supply available. Please contact wholesaler for availability. Somerset is ramping up production to meet increased demand. Demand increase for the drug
10mg/mL 10 vials (NDC 70069-151-10) Limited supply available. Please contact wholesaler for availability. Somerset is ramping up production to meet increased demand. Demand increase for the drug

Teva Pharmaceuticals (Revised 08/04/2020)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
200 mg/20 mL (10 mg/mL) Single-dose vials (NDC 0703-2045-03) This product is on allocation, however we are satisfying historical committed customer demand. We cannot take on any additional demand Teva is experiencing a significant increase in demand, due in part to the pandemic Demand increase for the drug
20 mg/10 mL (2 mg/mL) Multiple-dose vials (NDC 0703-2056-03) This product is on allocation, however we are satisfying historical committed customer demand. We cannot take on any additional demand Teva is experiencing a significant increase in demand, due in part to the pandemic Demand increase for the drug
10 mg/5 mL (2 mg/mL) Single-dose vials (NDC 0703-2033-03) Backordered. Resupply expected September 2020. Teva is experiencing a significant increase in demand, due in part to the pandemic Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English